Published in Clin Chim Acta on March 16, 1987
Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood (2006) 1.23
Monokines regulate glycosylation of acute-phase proteins. J Exp Med (1987) 1.15
Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein. Glycoconj J (1997) 1.06
Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol (1997) 1.03
Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines. Clin Exp Immunol (1989) 0.97
Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels. Clin Exp Immunol (1990) 0.83
Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV. Ann Rheum Dis (2001) 0.79
Studies on the interaction between hyaluronan and a rat colon cancer cell line. Glycoconj J (1998) 0.77
Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? Ann Rheum Dis (1993) 0.77
Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro. Ann Rheum Dis (1992) 0.75
alpha1-Acid glycoprotein production in rat dorsal air pouch in response to inflammatory stimuli, dexamethasone and honey bee venom. Exp Mol Pathol (2010) 0.75
The incorporation of various porphyrins into blood cells measured via flow cytometry, absorption and emission spectroscopy. Acta Biochim Pol (1998) 2.04
The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol (1993) 2.01
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci (1995) 1.36
Acute phase proteins as disease markers. Dis Markers (1987) 1.35
BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat (2006) 1.33
Indicators of immune activation in major depression. Psychiatry Res (1996) 1.30
IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol (2001) 1.28
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene (1999) 1.24
A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet (2005) 1.22
Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells. J Immunol (1988) 1.16
Monokines regulate glycosylation of acute-phase proteins. J Exp Med (1987) 1.15
Recent developments in renal cell cancer immunotherapy. Expert Opin Biol Ther (2007) 1.09
Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol (1981) 1.08
Serum interleukin-8 level is increased in diabetic patients. Diabetologia (1999) 1.06
Novel BRCA1 mutations and more frequent intron-20 alteration found among 236 women from Western Poland. Oncogene (1997) 1.00
Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Cancer (2000) 0.98
Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus. Arthritis Rheum (1987) 0.98
Determination of lectin-sugar dissociation constants by agarose affinity electrophoresis. Anal Biochem (1986) 0.96
Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiol (2013) 0.95
BRCA2 germline mutations in male breast cancer patients in the Polish population. Hum Mutat (2001) 0.93
C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol (1993) 0.92
Direct quantitation of skin elasticity in systemic sclerosis. J Rheumatol (1990) 0.89
[Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis]. Med Klin (Munich) (1993) 0.88
No evidence of HTLV-I infection in patients with mycosis fungoides and Sezary syndrome. Neoplasma (2005) 0.88
Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol (1996) 0.88
Interleukin-6-type cytokine-induced changes in acute phase protein glycosylation. Ann N Y Acad Sci (1995) 0.88
Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in patients with rheumatoid arthritis. Arthritis Rheum (1989) 0.88
The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells. Oncogene (2001) 0.87
Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer. Cancer Gene Ther (2010) 0.87
Still's disease in children and adults: a distinct pattern of acute-phase proteins. Clin Rheumatol (1998) 0.86
Effector mechanisms in allograft rejection. IV. In contrast to late cytotoxic cells, and early killer cells infiltrating mouse sponge matrix allografts are predominantly T lymphocytes. Cell Immunol (1978) 0.86
TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int (2000) 0.86
Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy. Blood (1994) 0.85
Loss of tumorigenicity of murine colon carcinoma MC38/0 cell line after transduction with a retroviral vector carrying murine IL-12 genes. Folia Biol (Praha) (2004) 0.84
Comparison of three immunoassays for C-reactive protein determination. Arch Immunol Ther Exp (Warsz) (1985) 0.84
Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand J Rheumatol Suppl (2004) 0.83
Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancer. Int J Oncol (1996) 0.82
Glycosylation of alpha 1-acid glycoprotein in systemic onset juvenile rheumatoid arthritis and acute bacterial infection: value in differential diagnosis. J Rheumatol (1993) 0.82
New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancer. Cancer Lett (1997) 0.82
The in vitro production of alpha--fetoprotein variants by human fetal organs. Oncodev Biol Med (1980) 0.82
Development of a double-copy bicistronic retroviral vector for human gene therapy. Adv Exp Med Biol (1998) 0.81
The differences in the expression of CD45 isoforms on peripheral blood lymphocytes derived from patients with seasonal or perennial atopic allergy. Tohoku J Exp Med (1997) 0.80
Gene-modified cellular vaccines: technologic aspects and clinical problems. Transplant Proc (2010) 0.80
Interleukin 10 inhibits interleukin 6 production and acute phase response in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) (1995) 0.80
Cytochemical studies of peripheral blood granulocytes and lymphocytes in patients with systemic lupus erythematosus. Pol Med Sci Hist Bull (1976) 0.80
Role of TH1/TH2 cytokines in kidney allograft rejection. Transplant Proc (2008) 0.80
Minor microheterogeneity of alpha 1-acid glycoprotein in rheumatoid arthritis. Prog Clin Biol Res (1989) 0.79
Induction of C-reactive protein by cytokines in human hepatoma cell lines is potentiated by caffeine. Biochem J (1990) 0.79
The importance of ceruloplasmin oxidase activity in patients with chronic lower limb atherosclerotic ischemia. Int Angiol (2007) 0.79
Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein. Glycoconj J (1998) 0.79
Human cancer gene therapy with cytokine gene-modified cells. Expert Opin Biol Ther (2004) 0.79
Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis. J Rheumatol (1993) 0.79
Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development. Gene Ther (1997) 0.79
Novel BRCA2 mutation in a Polish family with hamartoma and two male breast cancers. J Med Genet (2002) 0.79
The usefulness of CD4/CD8 ratio evaluation in monitoring of ovarian cancer patients. Eur J Gynaecol Oncol (1995) 0.79
Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer. Expert Opin Biol Ther (2001) 0.78
[An unusual case of Kartagener's syndrome associated with rheumatoid arthritis]. Pol Arch Med Wewn (1996) 0.78
[Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes]. Pol Arch Med Wewn (2001) 0.78
Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice. Cancer Gene Ther (2000) 0.78
Distinct cytokine patterns in different states of kidney allograft function. Transplant Proc (2009) 0.78
Interleukin-6-type cytokines affect glycosylation of acute phase proteins in vitro. Ann N Y Acad Sci (1995) 0.78
[The heteroglycan profile of acute phase proteins in the differentiation of inflammatory processes]. Z Rheumatol (1990) 0.78
C-reactive protein and alpha 1-acid glycoprotein in monitoring of patients with acute arterial occlusion. Eur J Vasc Surg (1991) 0.78
Composition, subclass distribution, and preliminary analysis of the functions of host inflammatory cells infiltrating renal allografts during rejection. Transplant Proc (1979) 0.78
Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? Ann Rheum Dis (1993) 0.77
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo. Leukemia (2001) 0.77
Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol (2013) 0.77
Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins? Ups J Med Sci (1995) 0.77
IL-11 is a potent anti-melanoma factor. Adv Exp Med Biol (2001) 0.77
Affinity electrophoresis for diagnosis of cancer and inflammatory conditions. Electrophoresis (1989) 0.77
Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study. Eur J Gynaecol Oncol (1992) 0.77
The binding of SRBC by human peripheral blood monocytes. Immunol Lett (1983) 0.77
The role of Foxp3+ regulatory T cells in kidney transplantation. Transplant Proc (2009) 0.77
C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs. Eur J Vasc Surg (1993) 0.77
Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A. Behring Inst Mitt (1986) 0.77
Genetically modified dendritic cells--a new, promising cancer treatment strategy? Expert Opin Biol Ther (2002) 0.76
Changes of acute phase proteins glycosylation profile as a possible prognostic marker in myocardial infarction. Int J Cardiol (1995) 0.76
Genetically modified tumour vaccines--where we are today. Cancer Treat Rev (1999) 0.76
Cytochemical studies of rosette-forming cells. Z Immunitatsforsch Exp Klin Immunol (1975) 0.76
Recent developments in retroviral gene delivery systems. Expert Opin Biol Ther (2001) 0.76
The interactions of phthalocyanines with stimulated and resting human peripheral blood mononuclear cells. Acta Biochim Pol (2001) 0.76
Genetically modified tumour vaccines (GMTV) in melanoma clinical trials. Immunol Lett (2000) 0.76
Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder. J Affect Disord (1996) 0.76
Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med (1996) 0.76
Intense acute phase response in ischemic patients. Int J Cardiol (1999) 0.75
The effect of methotrexate and azathioprine on the serum levels of IgA-alpha 1-antitrypsin complex in juvenile chronic arthritis. Braz J Med Biol Res (1997) 0.75
Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide. Z Rheumatol (1994) 0.75
An influence of immunomodulation on Th1 and Th2 immune response in endometriosis in an animal model. Biomed Res Int (2013) 0.75
Microheterogeneity of alpha 1-acid glycoprotein in patients with rheumatoid arthritis. Ann Rheum Dis (1994) 0.75
Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro. Ann Rheum Dis (1992) 0.75
C-reactive protein in management of children's burns. Ann Clin Res (1987) 0.75
[Immunoglobulin receptors on the surface of peripheral blood lymphocytes in patients with rheumatoid arthritis]. Pol Arch Med Wewn (1975) 0.75
Effect of cyclophosphamide on the immune response to sheep erythrocytes in the mouse. I. A study of cytological events in the draining lymph node. Z Immunitatsforsch Exp Klin Immunol (1974) 0.75